{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:36:43Z","timestamp":1791607003157,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.13386.BD"],"award-info":[{"award-number":["2022.13386.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-024-05369-4","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:31:23Z","timestamp":1732779083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Can the free\/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy?"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8076-4550","authenticated-orcid":false,"given":"Rui M.","family":"Bernardino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi B.","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lajkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica G.","family":"Cockburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian S.","family":"Wettstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixon","family":"Woon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David-Dan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Sayyid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Le\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"5369_CR1","doi-asserted-by":"crossref","unstructured":"van Leenders GJLH, van der Kwast TH, Iczkowski KA (2021) The 2019 International Society of Urological Pathology Consensus Conference on prostate Cancer grading. Eur Urol 79(6):707\u2013709","DOI":"10.1016\/j.eururo.2020.08.004"},{"issue":"4","key":"5369_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","volume":"145","author":"JI Epstein","year":"2021","unstructured":"Epstein JI, Amin MB, Fine SW, Algaba F, Aron M, Baydar DE et al (2021) The 2019 Genitourinary Pathology Society (GUPS) White Paper on contemporary grading of prostate Cancer. Arch Pathol Lab Med 145(4):461\u2013493","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"5369_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.eururo.2017.04.034","volume":"72","author":"MLK Chua","year":"2017","unstructured":"Chua MLK, Lo W, Pintilie M, Murgic J, Lalonde E, Bhandari V et al (2017) A prostate Cancer Nimbosus: genomic instability and SChLAP1 dysregulation underpin aggression of Intraductal and Cribriform Subpathologies[Figure presented]. Eur Urol 72(5):665\u2013674","journal-title":"Eur Urol"},{"issue":"3","key":"5369_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4081\/aiua.2020.3.235","volume":"92","author":"RM Bernardino","year":"2020","unstructured":"Bernardino RM, Carvalho R, Severo L, Alves M, Papoila AL, Pinheiro C (2020) Prostate cancer with cribriform pattern: exclusion criterion for active surveillance? Arch Ital Urol Androl 92(3):235\u2013238","journal-title":"Arch Ital Urol Androl"},{"issue":"3","key":"5369_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/modpathol.2014.116","volume":"28","author":"CF Kweldam","year":"2015","unstructured":"Kweldam CF, Wildhagen MF, Steyerberg EW, Van Der Bangma CH, Van Leenders GJLH (2015) Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. Mod Pathol 28(3):457\u2013464","journal-title":"Mod Pathol"},{"issue":"1","key":"5369_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","volume":"32","author":"E Hollemans","year":"2019","unstructured":"Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Helleman J, Roobol MJ et al (2019) Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis. Mod Pathol 32(1):139\u2013146","journal-title":"Mod Pathol"},{"key":"5369_CR7","doi-asserted-by":"crossref","unstructured":"Bernardino R, Sayyid RK, Lajkosz K, Al-Daqqaq Z, Tiwari R, Cockburn J et al Intraductal Prostate Cancer Affinity for Lymphatic-Predominant Metastases Through 18F-DCFPyL\u2013Prostate-Specific Membrane Antigen\u2013Positron Emission Tomography\/CT Scans in Pretreatment Prostate Cancer Patients. J Urol [Internet]. 2024 Feb [cited 2024 Feb 6]; https:\/\/pubmed.ncbi.nlm.nih.gov\/38299501\/","DOI":"10.1097\/JU.0000000000003850"},{"key":"5369_CR8","unstructured":"Bernardino R, Sayyid RK, Al-Daqqaq Z, Tiwari R, Cockburn J, Vijayakanthan S et al Lymphotropic Pattern of Prostate-specific Membrane Antigen\u2013detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform Disease. Eur Urol Focus [Internet]. 2023 May [cited 2023 Jun 1];0(0). http:\/\/www.eu-focus.europeanurology.com\/article\/S2405456923001165\/fulltext"},{"key":"5369_CR9","unstructured":"Bernardino RM, Sayyid RK, Lajkosz K, Al-Daqqaq Z, Cockburn JG, Chavarriaga J et al Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer. Eur Urol Focus [Internet]. 2023 Sep [cited 2023 Sep 24]; https:\/\/pubmed.ncbi.nlm.nih.gov\/37696743\/"},{"key":"5369_CR10","doi-asserted-by":"publisher","unstructured":"Magklara A, Scorilas A, Catalona WJ, Diamandis EP The Combination of Human Glandular Kallikrein and Free Prostate-specific Antigen (PSA) Enhances Discrimination Between Prostate Cancer and Benign Prostatic Hyperplasia in Patients with Moderately Increased Total PSA. Clin Chem [Internet]. 1999 Nov 1 [cited 2024 Feb 4];45(11):1960\u20136. https:\/\/doi.org\/10.1093\/clinchem\/45.11.1960","DOI":"10.1093\/clinchem\/45.11.1960"},{"key":"5369_CR11","doi-asserted-by":"crossref","unstructured":"Luderer AA, Chen YT, Soriano TF, Kramp WJ, Carlson G, Cuny C et al (1995) Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology [Internet]. [cited 2024 Jan 14];46(2):187\u201394. https:\/\/pubmed.ncbi.nlm.nih.gov\/7542820\/","DOI":"10.1016\/S0090-4295(99)80192-7"},{"key":"5369_CR12","doi-asserted-by":"crossref","unstructured":"Magklara A, Scorilas A, Catalona WJ, Diamandis EP (1999) The Combination of Human Glandular Kallikrein and Free Prostate-specific Antigen (PSA) Enhances Discrimination Between Prostate Cancer and Benign Prostatic Hyperplasia in Patients with Moderately Increased Total PSA. [cited 2024 Jan 14]; https:\/\/academic.oup.com\/clinchem\/article\/45\/11\/1960\/5643412","DOI":"10.1093\/clinchem\/45.11.1960"},{"key":"5369_CR13","doi-asserted-by":"crossref","unstructured":"Ferraro S, Biganzoli G, Bussetti M, Castaldi S, Biganzoli EM, Plebani M Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management. Clin Chem Lab Med [Internet]. 2022 Jan 1 [cited 2024 May 14];61(1):142\u201353. https:\/\/pubmed.ncbi.nlm.nih.gov\/36322977\/","DOI":"10.1515\/cclm-2022-0874"},{"key":"5369_CR14","unstructured":"Prostate Cancer - INTRODUCTION - Uroweb [Internet]. [cited 2023 May 29]. https:\/\/uroweb.org\/guidelines\/prostate-cancer"},{"key":"5369_CR15","doi-asserted-by":"crossref","unstructured":"Treurniet KM, Trudel D, Sykes J, Evans AJ, Van Der Finelli A (2014) Downgrading of biopsy based Gleason score in prostatectomy specimens. J Clin Pathol [Internet]. [cited 2023 Sep 26];67(4):313\u20138. https:\/\/pubmed.ncbi.nlm.nih.gov\/24403214\/","DOI":"10.1136\/jclinpath-2012-201323"},{"issue":"3","key":"5369_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/his.13747","volume":"74","author":"M Masoomian","year":"2019","unstructured":"Masoomian M, Downes MR, Sweet J, Cheung C, Evans AJ, Fleshner N et al (2019) Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set. Histopathology 74(3):474\u2013482","journal-title":"Histopathology"},{"key":"5369_CR17","doi-asserted-by":"crossref","unstructured":"Hoffman RM, Clanon DL, Littenberg B, Frank JJ, Peirce JC (2000) Using the Free-to-total Prostate-specific Antigen Ratio to Detect Prostate Cancer in Men with Nonspecific Elevations of Prostate-specific Antigen Levels. J Gen Intern Med [Internet]. [cited 2024 Apr 15];15(10):739. http:\/\/www.pmc\/articles\/PMC1495603\/","DOI":"10.1046\/j.1525-1497.2000.90907.x"},{"key":"5369_CR18","doi-asserted-by":"crossref","unstructured":"Bernardino R, Fleshner N, Re Sensitivity of Multiparametric MRI and Targeted Biopsy for Detection of Adverse Pathologies (Cribriform Gleason Pattern 4 and Intraductal Carcinoma): Correlation of Detected and Missed Prostate Cancer Foci with Whole Mount Histopathology. Eur Urol [Internet]. 2023 [cited 2023 May 12]; https:\/\/pubmed.ncbi.nlm.nih.gov\/36792385\/","DOI":"10.1016\/j.eururo.2023.01.028"},{"key":"5369_CR19","doi-asserted-by":"crossref","unstructured":"Belue MJ, Blake Z, Yilmaz EC, Lin Y, Harmon SA, Nemirovsky DR et al Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI? Prostate [Internet]. 2023 Dec 1 [cited 2024 Jan 4];83(16):1519\u201328. https:\/\/pubmed.ncbi.nlm.nih.gov\/37622756\/","DOI":"10.1002\/pros.24610"},{"issue":"4","key":"5369_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/pros.24291","volume":"82","author":"A Mikoshi","year":"2022","unstructured":"Mikoshi A, Miyai K, Hamabe F, Edo H, Ito K, Matsukuma S et al (2022) MRI-detectability and histological factors of prostate cancer including intraductal carcinoma and cribriform pattern. Prostate 82(4):452\u2013463","journal-title":"Prostate"},{"key":"5369_CR21","doi-asserted-by":"crossref","unstructured":"Masoomian M, Downes MR, Sweet J, Cheung C, Evans AJ, Fleshner N et al Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set. Histopathology [Internet]. 2019 Feb 1 [cited 2023 May 28];74(3):474\u201382. https:\/\/pubmed.ncbi.nlm.nih.gov\/30160779\/","DOI":"10.1111\/his.13747"},{"key":"5369_CR22","doi-asserted-by":"crossref","unstructured":"Hollemans E, Verhoef EI, Bangma CH, Schoots I, Rietbergen J, Helleman J et al Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens. Histopathology [Internet]. 2019 [cited 2023 May 28];75(3):338\u201345. https:\/\/pubmed.ncbi.nlm.nih.gov\/31045262\/","DOI":"10.1111\/his.13893"},{"key":"5369_CR23","doi-asserted-by":"crossref","unstructured":"Balk SP, Ko YJ, Bubley GJ Biology of prostate-specific antigen. J Clin Oncol [Internet]. 2003 Jan 15 [cited 2024 Apr 13];21(2):383\u201391. https:\/\/pubmed.ncbi.nlm.nih.gov\/12525533\/","DOI":"10.1200\/JCO.2003.02.083"},{"key":"5369_CR24","doi-asserted-by":"crossref","unstructured":"Murray NP, Reyes E, Orellana N, Fuentealba C, Due\u00f1as R (2014) A comparative performance analysis of total PSA, percentage free PSA, PSA velocity, and PSA density versus the detection of primary circulating prostate cells in predicting initial prostate biopsy findings in Chilean men. Biomed Res Int [Internet]. [cited 2024 Apr 13];2014. https:\/\/pubmed.ncbi.nlm.nih.gov\/25101294\/","DOI":"10.1155\/2014\/676572"},{"key":"5369_CR25","unstructured":"Elabbady AA, Khedr MM Free\/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3\u201310 ng\/ml"},{"key":"5369_CR26","doi-asserted-by":"crossref","unstructured":"Lattouf JB Reflexive ordering of percent free PSA in patients: Do we need to ask the question? Canadian Urological Association Journal [Internet]. 2010 Oct [cited 2024 Apr 13];4(5):321. http:\/\/www.pmc\/articles\/PMC2950780\/","DOI":"10.5489\/cuaj.903"},{"key":"5369_CR27","doi-asserted-by":"publisher","unstructured":"Magklara A, Scorilas A, Catalona WJ, Diamandis EP The Combination of Human Glandular Kallikrein and Free Prostate-specific Antigen (PSA) Enhances Discrimination Between Prostate Cancer and Benign Prostatic Hyperplasia in Patients with Moderately Increased Total PSA. Clin Chem [Internet]. 1999 Nov 1 [cited 2024 Apr 13];45(11):1960\u20136. https:\/\/doi.org\/10.1093\/clinchem\/45.11.1960","DOI":"10.1093\/clinchem\/45.11.1960"},{"key":"5369_CR28","doi-asserted-by":"crossref","unstructured":"Catalona WJ (1996) Clinical utility of measurements of free and total prostate-specific antigen (PSA): A review. In: Prostate. pp. 64\u20139","DOI":"10.1002\/(SICI)1097-0045(1996)7+<64::AID-PROS9>3.0.CO;2-J"},{"key":"5369_CR29","unstructured":"Wong HY, Sheng Q, Hesterberg AB, Croessmann S, Rios BL, Giri K et al Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease. Nature Communications 2022 13:1 [Internet]. 2022 Oct 13 [cited 2024 Sep 22];13(1):1\u201321. https:\/\/www.nature.com\/articles\/s41467-022-33780-1"},{"key":"5369_CR30","doi-asserted-by":"crossref","unstructured":"Bernardino R, Carvalho AS, Hall MJ, Alves L, Le\u00e3o R, Sayyid R, et al. Profiling of urinary extracelullar vesicle protein signatures from patients with cribriform and intraductal prostate cancer in a cross-sectional study. Sci Rep. 2024. PMID: 3944354439443544.","DOI":"10.1038\/s41598-024-75272-w"},{"key":"5369_CR31","doi-asserted-by":"crossref","unstructured":"Bernardino RM, Yin LB, Cockburn JG, Wettstein M, Sayyid RK, et al. Undetected Cribriform and Intraductal Prostate Cancer at biopsy is associated with adverse outcomes. Prostate Cancer Prostatic Dis. 2024. PMID: 39433886.","DOI":"10.1038\/s41391-024-00910-3"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05369-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-05369-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05369-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:27:41Z","timestamp":1735853261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-05369-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5369"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-05369-4","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Appropriate ethics approval was obtained from the University Health Network research ethics board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous presentations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"651"}}